Bridging the Gap From Soil to Oil Disclaimer Dis claimer This - - PowerPoint PPT Presentation

bridging the gap
SMART_READER_LITE
LIVE PREVIEW

Bridging the Gap From Soil to Oil Disclaimer Dis claimer This - - PowerPoint PPT Presentation

Bridging the Gap From Soil to Oil Disclaimer Dis claimer This presentation has been prepared by Nextleaf Solutions Ltd (Nextleaf or the Company). It does not purport to contain a ll the information that a prospective investor may


slide-1
SLIDE 1

Bridging the Gap From Soil to Oil

slide-2
SLIDE 2

This presentation has been prepared by Nextleaf Solutions Ltd (“Nextleaf” or the “Company”). It does not purport to contain all the information that a prospective investor may require in connection with any potential investment in the Company. You should not treat the contents of this presentation, or any information provided in connection with it, as financial advice, financial product advice or advice relating to legal, taxation or investment matters. No representation or warranty (whether express or implied) is made by Nextleaf or any of its officers, advisers, agents or employees as to the accuracy, completeness or reasonableness of the information, statements, opinions or matters (express or implied) arising out of, contained in or derived from this presentation or provided in connection with it, or any omission from this presentation, nor as to the attainability of any estimates, forecasts or projections set out in this presentation. This presentation is provided expressly on the basis that you will carry out your own independent inquiries into the matters contained in the presentation and make your own independent decisions about the affairs, financial position or prospects of the Company. Nextleaf reserves the right to update, amend or supplement the information at any time in its absolute discretion (without incurring any obligation to do so). Neither Nextleaf, nor their respective related bodies corporate, officers, their advisers, agents and employees accept any responsibility

  • r liability to you or to any other person or entity arising out of this presentation including pursuant to the general law (whether for negligence, under statute or
  • therwise), or under the Australian Securities and Investments Commission Act 2001, Corporations Act 2001, Competition and Consumer Act 2010 or any corresponding

provision of any Australian state or territory legislation (or the law of any similar legislation in any other jurisdiction), or under similar provision under any applicable law including securities laws in Canada. Any such responsibility or liability is, to the maximum extent permitted by law, expressly disclaimed and excluded. Nothing in this material should be construed as either an offer to sell or a solicitation of an offer to buy or sell securities. It does not include all available information and should not be used in isolation as a basis to invest in Nextleaf. This presentation is not a prospectus, offering memorandum, or a public offering of securities. Nextleaf may offer common shares only to investors whom Nextleaf believes to be qualified to participate under registration and prospectus exemptions under applicable securities

  • legislation. There is currently no public market for the resale of the common shares and such securities will be subject to restrictions under legislation that will vary

depending upon the relevant jurisdiction. An investment in the company involves a high degree of risk and only investors who can reasonably afford a loss of their entire investment should consider purchasing shares. This presentation contains reference to certain intentions, expectations, future plans, strategy and prospects of Nextleaf. Those intentions, expectations, future plans, strategy and prospects may or may not be achieved. They are based on certain assumptions, which may not be met or on which views may differ and may b affected by known and unknown risks. The performance and operations of Nextleaf may be influenced by a number of factors, many of which are outside the control of the Company. No representation or warranty, express or implied, is made by the Company, or any of their respective directors, officers, employees, advisers or agents that any intentions, expectations or plans will be achieved either totally or partially or that any particular rate of return will be achieved. Given the risks and uncertainties that may cause Nextleaf actual future results, performance or achievements to be materially different from those expected, planned or intended, recipients should not place undue reliance on these intentions, expectations, future plans, strategy and prospects.

Dis Disclaimer claimer

slide-3
SLIDE 3

Highly concentrated THC or CBD distillate is odourless, tasteless, and standardized for potency Nextleaf’s patented process will disrupt the production of infused edibles, vape pens, and beverages - legal in Canada by October 2019 Nextleaf commercializes its technology through toll processing and white label oils production.

Disruptive Technology

Nextleaf (CSE: OILS) owns a portfolio of issued and pending patents for the process of producing cannabinoid distillate, the precursor of every cannabis infused product

slide-4
SLIDE 4

The flavours and aromas of cannabis are undesirable in edible and infused products made with crude extract due to chlorophyll, fats, lipids and other impurities Nextleaf has been issued a U.S. patent pertaining to the Company’s industrial-scale process of extraction and purification of cannabinoids The U.S. patent covers the process of transforming dried cannabis into high-purity THC or CBD distillate oil, simplifying the manufacturing of differentiated formulations and delivery methods Health Canada’s draft regulations to legalize infused products by October 2019 makes cannabinoid purification technology vital for the manufacturing of standardized edibles and vape pens

Patented Extraction & Purification Process

Through our patented technology, we produce a premium, purified cannabinoid distillate

slide-5
SLIDE 5

The secret to producing standardized and impurity free cannabis extracts is in the purification and refinement steps This goes above and beyond typical “crude extraction”, delivering a truly premium distillate THINK: PREMIUM VODKA VERSUS MOONSHINE

slide-6
SLIDE 6

Intel Intellectu lectual al Pr Prope

  • perty

rty Po Portfo rtfolio lio

Issued U.S. Patent: NLU001: End-to-End Process U.S. Patent scheduled to issue Q1 2019: NLU002: Cold Filtration Patents Pending: NLU003: Process and system NLU004: Extraction using chilling system Total of 18 patents pending in:

United States, Canada, Mexico, Colombia, Jamaica, Europe, Australia

slide-7
SLIDE 7

There is an ample supply of low-quality cannabis and hemp biomass and a lack of extraction and processing capacity in the industry Nextleaf provides processing to licensed cultivators, and supplies cannabis oil and extracts to qualified Canadian and international B2B partners under their own brand

Turning ”Garbage” into Gold

slide-8
SLIDE 8

Extracts: The Industry’s Fastest Growing Segment

Nextleaf’s patented technology allows for low quality dried cannabis biomass, including failed crops, to be processed into high-purity distillate oil

slide-9
SLIDE 9

Infused Products: In the Media

Companies es that secure re unique e IP firs rst t will have a competi titive tive advantage ge. . IP categorie ies that a are most lucrative, e, are those that don’t relate to the actual plant, but to processing and pharmaceutical applications” – Financial Post Infused ed edible les and b beverages ges contain consist isten ent doses es of cannabis oil and h have a r reprod

  • ducible

ible effec fect, , while the e effec fects ts from m smoking ing cannabis can v vary widely

  • ly. Edible

les may co come with even higher demand.” – CBC News ws Six out of

  • f 10 C

Canadian customers ers would choose e pot edibles es

  • ver smokable

les” - Deloitt itte

slide-10
SLIDE 10

The Mobile Lab travels to licensed production sites, operating under the client’s processing license Fully equipped to process 20 kg/hour of biomass into cannabis oil Through a toll processing model, the Lab allows small producers to avoid the capital investment of

  • il production

Exclusive manufacturing agreement with K-Line Trailers

Mo Mobile bile Extr Extractio action n Lab Lab

Nextleaf has developed a first

  • f its kind,

Mobile Extraction Lab

slide-11
SLIDE 11

Toll processing and white-label oils production

6,540 sq. ft. processing facility in Greater Vancouver

Capacity to process 100 tons of cannabis per year Research lab for testing and formulations 40 mins from Vancouver International Airport 9M sq. ft. of cannabis cultivation within 60 mins Standard Processor License expected Q2-Q3 2019

Ce Centr ntraliz alized ed Pr Proces

  • cessing

sing Facil Facility ity

slide-12
SLIDE 12

Nextleaf develops proprietary formulations for infused products with THC and CBD distillate, significantly increasing speed-to-market for our B2B partners

TOPICALS, SKINCARE & TRANSDERMAL DELIVERY SPECIALTY CONCENTRATES VAPE TECHNOLOGY EDIBLE OILS BEVERAGES & WATER-SOLUBLE EXTRACTS

Letter of Intent (LOI) signed with BevCanna for supply of oils Patent obtained for tasteless, odourless ingestible oil Patented process allows for easy dosing, scalable production Patent filed for process to concentrate resinous glands in the plant. Letter of Intent (LOI) signed with Omni Bioceuticals

Pr Prod

  • duct

uct Fo Formul rmulat atio ion

slide-13
SLIDE 13

About BevCanna:

40,000 sq. ft. $30M bottling facility in Osoyoos, B.C. HACCP Certified and Health Canada approved facility 315 acres of Agriculture Reserved Land with Canadian alkaline spring water aquifer on-site Capacity for 40 million bottles annually

Infused Beverage Partnership with BevCanna

Nextleaf has LOI with BevCanna for supply of oils pending Health Canada license Nano-emulsified water-soluble THC and CBD used in all BevCanna infused beverages to be produced at Nextleaf’s processing facility

Long term kinetic stability: no settling/separation Superior mouthfeel: no texture or residue Fast onset, high bioavailability Nextleaf earns licensing fees from all products derived from its IP

slide-14
SLIDE 14

National Research Council of Canada

Industrial Research Assistance Program (IRAP) Research Focus: Development of processing techniques for removing chlorophyll and other impurities from crude oil extract

Sustainable Development Technology Canada

Nextleaf is part of SDTC consortium with Terramera Research Focus: Replacing toxic chemical pesticides with pesticides derived from natural products

Natural Science & Engineering Research Council (NSERC)

Research partnership with UBC and BCIT Research Focus: Methods for repurposing incinerated cannabis waste biomass for industrial construction.

Research & Development: Government Grants

slide-15
SLIDE 15

Paul Pedersen, MBA

CO CO-FOU FOUND NDER, ER, CEO EO, , DIR DIRECTO ECTOR

Charles Ackerman, CPA, CA

CFO, FO, DIR DIRECTO ECTOR

Ryan Ko

CO CO-FOU FOUND NDER, ER, CTO TO 15+ year career in the cannabis industry, Ryan has developed deep expertise and intellectual property within extraction technology, leading to one of Canada's first patents for cannabis extraction and

  • distillation. One of the early

adopters of the legal medical cannabis program in Canada. Paul has been focused on the cannabis industry since 2013, consulting for a variety of cannabis companies and investors, including Canada’s first cannabis oil producer and leading seed-to-sale software

  • provider. Paul holds an MBA

(finance) from Michigan State. Founder of NASDAQ: TWER. Charles has successfully lead mergers and acquisitions, divestitures and private and public capital raises. He has served in a number of finance and corporate leadership roles developing and executing growth strategies, with private and public companies and family offices across Canada. Dr Paul MacLeman has over 25 years of board and executive experience across life sciences and , agricultural sectors; encompassing technical, commercial and financial areas. He Chairs the committee reviewing the National Vocational Education Training Package in Pharmaceuticals.

Paul MacLeman

NO NON-EXECUT EXECUTIVE VE DIR DIRECTO ECTOR R

Execut Executive ive Off Officer icers & s & Bo Board ard of D

  • f Dire

irector ctors

slide-16
SLIDE 16

Strategic Operations

Krupal Pal, PhD, P.Eng

MAN ANAG AGER ER OF EN F ENGINE NEERI ERING NG

  • Dr. Pal has been working in process engineering

since 2005, applying fundamental chemical engineering and applied science principles to problems in many diverse fields including oils and extraction technologies, biodiesel processing and petrochemical industry.

Tom Ulanowski, MSc, C.Chem

PRESI RESIDE DENT NT, , NE NEXTL TLEA EAF F LAB ABS

Former Quality Assurance Person (QAP), Manager and Qualified Person in Charge (QPIC) at Canna Farms, BC’s first Licensed

  • Producer. Chartered Chemist, HBSc in

Analytical Chemistry from the University of Toronto, MSc. in Biogeochemistry from the University of Western Ontario.

Emma Andrews, BA, NPDP

DIRECTOR OF MARKETING

Taran Grey

DIR DIRECTO ECTOR R OF F INT NTEL ELLEC ECTU TUAL PROP ROPERTY ERTY

Over the past 10 years Emma’s led product innovation, consumer and retail education programs for global lifestyle brands. Most recently, Emma was a Partner, and Co- Founder of a multi-national strategic consulting company. Successfully tripled the size of the patent and trademark portfolios for firms he’s worked with, while reducing the aggregate total IP expenses incurred. Taran has managed IP protection at major international tech companies.

Science & Innovation

slide-17
SLIDE 17

Mile Milesto stone ne Mo Moments ments

Acquired intellectual property Mobile Lab completed U.S. Patent issued SDTC $2.5m consortium grant Completion

  • f Centralized

Processing Facility First U.S. Patent filed National Research Council grant Announced reverse takeover LOI with BevCanna for beverage R&D and supply

slide-18
SLIDE 18

Next Next 12 12 Mo Months nths

Obtai ain n licen ensin sing g at process essing g facility

1

Supply ply agree reemen ments with licen ensed sed cultiva vators 2 File e 20 addit ditional nal paten ents s around d methodol dology gy and formul mulation 4 Edible bles & infuse sed d produ ducts s legal gal in Canad nada a by Oct 2019 6 Commen mence e reve venu nue e from m B2B white e label bel produ duction and toll process essing

3

Infused sed beve verage rage formu mulat ations ns and stabil bility y trial als s with BevCann vCanna

5

Now Now 1 Year ear

slide-19
SLIDE 19

Nextleaf eaf Solutions

  • ns trades on t

the CSE under the t ticker symbol l OILS

Ca Capita pitaliz lizati ation

  • n Table

Table

Total shares outstanding (basic) 96,626,130 shares Stock options, exercisable at 35 cents 14,100,000 shares Warrants from RTO financing, exercisable 70 cents 14,285,714 shares Broker warrants, exercisable at 35 cents 569,446 shares Total shares outstanding (fully diluted) 125,581,29 581,290 0 shares

slide-20
SLIDE 20

SCIENCE AND INNOVATION FOCUSED First to market with patented technology for the purification of cannabinoids Nextleaf’s PATENTED PROCESSES will impact how edibles, beverages and

  • ther value-added products

are manufactured, once legalized in Canada and

  • ther international markets

TECHNOLOGY TO PROCESS abundant supply of low-quality cannabis biomass into high-purity oil, and isolate cannabinoids for proprietary formulations and delivery methods Opportunity for EARLY MARKET LEADERSHIP in high-margin infused product manufacturing SCALABLE WHITE LABEL PRODUCTION and toll processing solutions increase speed to market for Nextleaf B2B partners HIGHLY-EXPERIENCED TEAM, with longstanding credibility in the cannabis industry, including notable leaders and pioneers

Oppor Opportuni tunity ty Summary Summary

slide-21
SLIDE 21

Nextleaf Solutions Ltd. - Corporate Office Suite 304-68 Water Street, Vancouver, BC V6B1A4 604-283-2301 ext. 207 investors@nextleafsolutions.com